ATLASInvesco S&P SmallCap Momentum ETF (XSMO): outlook, holdings and fees
Invesco S&P SmallCap Momentum ETF (XSMO) is an exchange-traded fund and is managed by Invesco. The expense ratio is 0.40% and the yield is 0.62%. The ten largest holdings are 24% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on XSMO
| Last price | $80.70 (-0.3%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 53% |
| Likely 1-month range (50%) | $78.37 – $83.81 |
| Normal 1-day range (±1σ) | ±1.1% |
| Distribution yield | 0.62% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
XSMO fund facts
| Issuer | Invesco |
|---|---|
| Theme | Factor strategies |
| Assets under management | $2.9B |
| Expense ratio | 0.40% |
| Number of holdings | 50 |
| Portfolio turnover | 0% |
| Inception | Mar 3, 2005 |
| Exchange | NYSE |
Strictly in accordance with its guidelines and mandated procedures, the index provider compiles, maintains and calculates the underlying index, which is composed of constituents of the S&P SmallCap 600® Index that have the highest momentum score. Under normal circumstances, the fund will invest at least 80% of the value of its net assets, in the components of the underlying index and in derivatives and other investments that have economic characteristics similar to the components of the underlying index.
XSMO top holdings
| Holding | Sector | Weight |
|---|---|---|
| ViaSat Inc VSAT | Technology | 3.94% |
| Protagonist Therapeutics Inc PTGX | Healthcare | 2.84% |
| Victoria's Secret & Co VSCO | Consumer Cyclical | 2.66% |
| MaxLinear Inc MXL | Technology | 2.20% |
| Madison Square Garden Sports Corp MSGS | Communication Services | 2.32% |
| International Seaways Inc INSW | Energy | 2.13% |
| Ligand Pharmaceuticals Incorporated LGND | Healthcare | 2.12% |
| Glaukos Corp GKOS | Healthcare | 1.86% |
| Plexus Corp PLXS | Technology | 1.83% |
| Matson Inc MATX | Industrials | 1.81% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
XSMO sector breakdown
| Sector | Weight |
|---|---|
| Technology | 19.8% |
| Healthcare | 19.0% |
| Financial Services | 14.9% |
| Real Estate | 12.9% |
| Energy | 9.3% |
| Industrials | 6.8% |
| Consumer Cyclicals | 6.2% |
| Consumer Defensive | 4.4% |
| Communication Services | 3.7% |
| Basic Materials | 3.1% |
By region: North America 98.6%, Latin America 0.8%, Asia Developed 0.7%.
XSMO returns and risk
| Year to date | +14.5% |
|---|---|
| 1 year | +13.8% |
| 3 years (annualised) | +20.2% |
| 5 years (annualised) | +9.8% |
| 10 years (annualised) | +12.8% |
| Volatility (3 years) | 21.7% |
| Sharpe ratio (3 years) | 0.73 |
Past returns do not guarantee future results.
XSMO: frequently asked questions
What does XSMO invest in?
Invesco S&P SmallCap Momentum ETF invests in a portfolio of securities. Its largest holdings are ViaSat Inc (3.9%), Protagonist Therapeutics Inc (2.8%), Victoria's Secret & Co (2.7%), MaxLinear Inc (2.2%), Madison Square Garden Sports Corp (2.3%).
What is the XSMO expense ratio?
0.40% a year: about $40.00 for every $10,000 invested.
What is the XSMO dividend yield?
0.62%. ATLAS does not hold the exact distribution dates for ETFs.
Will XSMO go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 53%, with a likely range (50%) of $78.37 to $83.81 from $80.70 today. It is a probability, not a prediction.
How has XSMO performed?
Year to date +14.5%, one year +13.8%, three years +20.2% a year, five years +9.8% a year. Past returns do not guarantee future results.
Similar ETFs: Factor strategies
- iShares MSCI Intl Quality Factor ETF (IQLT)
- Invesco S&P MidCap Momentum ETF (XMMO)
- Invesco S&P MidCap Quality ETF (XMHQ)
- Invesco Russell 1000 Dynamic Multifactor ETF (OMFL)
- iShares MSCI Intl Momentum Factor ETF (IMTM)
- Invesco S&P 100 Equal Weight ETF (EQWL)
- Fidelity Small-Mid Multifactor ETF (FSMD)
- Invesco Dorsey Wright Momentum ETF (PDP)
Educational information, not investment advice. Disclaimer